GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » Forward Dividend Yield %

OBI Pharma (ROCO:4174) Forward Dividend Yield % : 0.00% (As of May. 23, 2025)


View and export this data going back to 2015. Start your Free Trial

What is OBI Pharma Forward Dividend Yield %?

As of today (2025-05-23), the Forward Annual Dividend Yield of OBI Pharma is 0.00%.

As of today (2025-05-23), the Trailing Annual Dividend Yield of OBI Pharma is 0.00%.

ROCO:4174's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.455
* Ranked among companies with meaningful Forward Dividend Yield % only.

OBI Pharma's Dividends per Share for the three months ended in Mar. 2025 was NT$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of OBI Pharma's Forward Dividend Yield %

For the Biotechnology subindustry, OBI Pharma's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OBI Pharma's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OBI Pharma's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where OBI Pharma's Forward Dividend Yield % falls into.


;
;

OBI Pharma Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


OBI Pharma  (ROCO:4174) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


OBI Pharma Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of OBI Pharma's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


OBI Pharma Business Description

Traded in Other Exchanges
N/A
Address
No. 508, Section. 7, Zhongxiao East Road, 6th Floor, Nangang District, Taipei, TWN, 115011
OBI Pharma Inc is a clinical-stage oncology company. It focuses on research and development for cancer therapies and aims to develop ground-breaking drugs. The core value lies in its passion to develop and deliver a portfolio of antibody-drug conjugates (ADCs) drugs for patients, in addition to its Globo H active immunotherapy. Its portfolio includes a spectrum of cancer targets, such as TROP2, Nectin-4, HER2, and other potential targets. These ADCs are built based on two distinct ADC technology platforms, with different characteristics. It offers a plug-and-play advantage through a specialized site-specific conjugation using a proprietary enzyme. Its segments are the anti-cancer new drug; bispecific monoclonal antibody new drug; botulinum toxin new drug; and CDMO segment.

OBI Pharma Headlines

No Headlines